Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer.

Skoulidis F, Li BT, de Langen AJ, Hong DS, Lena H, Wolf J, Dy GK, Curioni Fontecedro A, Tomasini P, Velcheti V, van der Wekken AJ, Dooms C, Paz-Ares Rodriguez L, Mountzios G, Sacher A, Nadal E, Couraud S, Kim SW, O'Byrne K, Rocco D, Toyozawa R, Chmielewska I, Lindsay CR, Hindoyan A, Mukundan L, Wilmanski T, Anderson A, Ardito-Abraham C, Pati A, Reddy A, Mehta B, Schuler M

Open source

DOI
10.1038/s41591-025-03732-5
Published
2025 Aug
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-025-03732-5,
  title = {Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer.},
  author = {Skoulidis F and Li BT and de Langen AJ and Hong DS and Lena H and Wolf J and Dy GK and Curioni Fontecedro A and Tomasini P and Velcheti V and van der Wekken AJ and Dooms C and Paz-Ares Rodriguez L and Mountzios G and Sacher A and Nadal E and Couraud S and Kim SW and O'Byrne K and Rocco D and Toyozawa R and Chmielewska I and Lindsay CR and Hindoyan A and Mukundan L and Wilmanski T and Anderson A and Ardito-Abraham C and Pati A and Reddy A and Mehta B and Schuler M},
  year = {2025},
  journal = {Nature medicine},
  doi = {10.1038/s41591-025-03732-5},
  url = {https://doi.org/10.1038/s41591-025-03732-5}
}

RIS

TY  - JOUR
TI  - Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer.
AU  - Skoulidis F
AU  - Li BT
AU  - de Langen AJ
AU  - Hong DS
AU  - Lena H
AU  - Wolf J
AU  - Dy GK
AU  - Curioni Fontecedro A
AU  - Tomasini P
AU  - Velcheti V
AU  - van der Wekken AJ
AU  - Dooms C
AU  - Paz-Ares Rodriguez L
AU  - Mountzios G
AU  - Sacher A
AU  - Nadal E
AU  - Couraud S
AU  - Kim SW
AU  - O'Byrne K
AU  - Rocco D
AU  - Toyozawa R
AU  - Chmielewska I
AU  - Lindsay CR
AU  - Hindoyan A
AU  - Mukundan L
AU  - Wilmanski T
AU  - Anderson A
AU  - Ardito-Abraham C
AU  - Pati A
AU  - Reddy A
AU  - Mehta B
AU  - Schuler M
PY  - 2025
JO  - Nature medicine
DO  - 10.1038/s41591-025-03732-5
UR  - https://doi.org/10.1038/s41591-025-03732-5
ER  - 

APA

F, S., BT, L., AJ, D. L., DS, H., H, L., J, W., GK, D., A, C. F., P, T., V, V., AJ, V. D. W., C, D., L, P. R., G, M., A, S., E, N., S, C., SW, K., K, O., D, R., R, T., I, C., CR, L., A, H., L, M., T, W., A, A., C, A., A, P., A, R., B, M., & M, S. (2025). Molecular determinants of sotorasib clinical efficacy in KRAS(G12C)-mutated non-small-cell lung cancer.. Nature medicine. https://doi.org/10.1038/s41591-025-03732-5

Source records